Pharmacogenetics in esophageal cancer

Seminars in Oncology

Volumn 32, Issue SUPPL. 9, 2005, Pages 87-89

  Wu, Xifeng ^a   Lu, Charles ^a   Chiang, Silvia S ^a   Ajani, Jaffer A ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 METHYLENETETRAHYDROFOLATE; 5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ANTINEOPLASTIC AGENT; CISPLATIN; FLUOROURACIL; FOLIC ACID DERIVATIVE; METHYLENETETRAHYDROFOLIC ACID; TAXANE DERIVATIVE; UNCLASSIFIED DRUG;

ADENOCARCINOMA; BIOMEDICINE; CANCER RESEARCH; CHEMOTHERAPY; CONFERENCE PAPER; DNA REPLICATION; DRUG METABOLISM; ENZYME POLYMORPHISM; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; GENETIC VARIABILITY; GENOTOXICITY; HUMAN; MAJOR CLINICAL STUDY; PHARMACOGENETICS; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME;

EID: 30544454934     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2005.04.031     Document Type: Conference Paper

References (11)

1. C.M. Ulrich, K. Robien, H.L. McLeod Cancer pharmacogenetics Polymorphisms, pathways and beyond Nature 3 2003 912 920
2. R. Weinshilboum Inheritance and drug response N Engl J Med 348 2003 529 537
3. J.A. Johnson Pharmacogenetics Potential for individualized drug therapy through genetics Trends Genet 19 2003 660 666
4. R. Nagasubramanian, F. Innocenti, M.J. Ratain Pharmacogenetics in cancer treatment Annu Rev Med 54 2003 437 452
5. A. Jemal, T. Murray, E. Ward Cancer Statistics, 2005 CA Cancer J Clin 55 2005 10 30
6. P.C. Enzinger, R.J. Mayer Esophageal cancer N Engl J Med 349 2003 2241 2251
7. J.I. Geh The use of chemoradiotherapy in oesophageal cancer Eur J Cancer 38 2002 300 313
8. A.J. Munro Oesophageal cancer A view over overviews Lancet 364 2004 566 568
9. K.-J. Sohn, R. Croxford, Z. Yates Effect of the methylenetetrahydrofolate reductase C677T polymorphism on chemosensitivity of colon and breast cancer cells to 5-fluorouracil and methotrexate J Natl Cancer Inst 96 2004 134 144
10. M.-C. Etienne, K. Ilc, J.-L. Formento Thymidylate synthase and methylenetetrahydrofolate reductase gene polymorphisms Relationships with 5-fluorouracil sensitivity Br J Cancer 90 2004 526 534
11. V. Cohen, V. Panet-Raymond, N. Sabbaghian Methylenetetrahydrofolate reductase polymorphism in advanced colorectal cancer A novel genomic predictor of clinical response to fluoropyrimidine-based chemotherapy Clin Cancer Res 9 2003 1611 1615